BioTelemetry's EBIT per Share for the
three
months ended in Sep. 2020 was $0.32.
Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2020 was $1.04.
During the past 12 months, the average EBIT per Share Growth Rate of BioTelemetry was -10.80% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 27.80% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 41.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for BioTelemetry's EBIT per Share or its related term are showing as below:
BEAT'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -63.2 Med: 37.05 Max: 138.3
Current: 27.8
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of BioTelemetry was 138.30% per year. The lowest was -63.20% per year. And the median was 37.05% per year.
BEAT's 3-Year EBIT Growth Rate is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 0.65
vs BEAT: 27.80
BioTelemetry's EBIT for the
three
months ended in Sep. 2020 was $11.6 Mil.
BioTelemetry EBIT per Share Historical Data
The historical data trend for BioTelemetry's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.04
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioTelemetry (NAS:BEAT) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
BioTelemetry EBIT per Share Related Terms
Thank you for viewing the detailed overview of BioTelemetry's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
BioTelemetry Inc provides monitoring services and digital population health management for healthcare providers, medical device manufacturing, and centralized core laboratory services for clinical research. It operates under healthcare, technology, and research segments. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials and the Technology segment, focuses on the development, manufacturing, testing, and marketing of cardiovascular and blood glucose monitoring devices to medical companies, clinics and hospitals.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BEAT has been successfully added to your 